Roche Holding AG Virtual Early Drug Development pRED Event Call Transcript
Ladies and gentlemen, welcome to the Roche Virtual Early Drug Development pRED Event 2019 Conference Call. I am Sharry, the Chorus Call operator. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Mr. Karl Mahler, Head of Investor Relations. Please go ahead, sir.
Yes. So good morning, and good afternoon, ladies and gentlemen. This is actually the first of 2 events we will do for the early stage setup, so our research engine, I would like to say. So we will have this -- today's focused on pRED, but we will have another one also in early next year, focusing on the Genentech early research and development.
Today, I'm joined by William Pao, the Head of the pRED Research Engine. He will give us an overview and introduction on the setup. We have Christian Rommel with us, the Global Head of pRED Oncology. Neuroscience will be represented by Azad Bonni, Global Head of pRED and Rare Diseases. Ophthalmology, Sascha Fauser,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
